معرفی
Dr. Harold J. Burstein is a Professor of Medicine at Harvard Medical School and a clinician-researcher at the Dana-Farber Cancer Institute and Brigham and Women's Hospital in Boston. He serves as Director of Academic Partnerships Institute and is a leading expert in breast oncology, with a focus on clinical trials and treatment guidelines development.
Dr. Burstein's research interests center on breast cancer treatment, particularly in clinical trials for early-stage and advanced breast cancer. His work spans angiogenesis inhibitors, HER2-positive breast cancer, endocrine therapy, and treatment guidelines. He has led and participated in multiple clinical trials that have helped shape national and international breast cancer treatment standards. His research also explores optimal use of adjuvant endocrine therapy through computer modeling to prevent cancer recurrence.
Analysis of Dr. Burstein's recent publications (2023-2024) reveals a strong focus on precision medicine approaches to breast cancer treatment. His work spans guideline development through organizations like NCCN and ESMO, investigation of novel therapeutic combinations (particularly for HER2-positive and hormone receptor-positive disease), and efforts to de-escalate therapy for patients with favorable responses. Much of his recent work addresses complex clinical questions around treatment sequencing, biomarker development, and optimizing therapy based on molecular subtypes.
- George P. Canellos Award for Excellence in Clinical Investigation and Patient Care (2001)
- Fellow of the American Society of Clinical Oncology (2012)
- Dana-Farber Cancer Institute Clinical Mentor Award (2014)
As a clinician-educator at Harvard Medical School, Dr. Burstein teaches students, residents, and fellows while maintaining an active clinical practice. His research program involves multiple clinical trials through the Dana-Farber/Harvard Cancer Center, with a focus on translating clinical observations into biological understanding. He has been instrumental in developing national treatment guidelines that influence breast cancer care worldwide. Dr. Burstein is recognized as one of the leading breast oncologists and is consistently named a 'Top Doctor' for breast cancer care.
Dr. Burstein works within the Breast Oncology Center at Dana-Farber Cancer Institute, collaborating with multidisciplinary teams including medical oncologists, surgeons, radiation oncologists, pathologists, and researchers to provide comprehensive care for breast cancer patients and advance the field through clinical investigation.
